Adaptimmune Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.6k | 12k | 0.13 |
| 2025-03-31 | $3.2k | 16k | 0.20 |
| 2024-12-31 | $8.7k | 16k | 0.54 |
| 2024-09-30 | $80k | 84k | 0.95 |
| 2024-06-30 | $16k | 16k | 0.97 |
| 2024-03-31 | $170k | 108k | 1.58 |
| 2023-12-31 | $13k | 16k | 0.79 |
| 2023-09-30 | $45k | 58k | 0.78 |
| 2023-06-30 | $45k | 48k | 0.93 |
| 2023-03-31 | $34k | 31k | 1.09 |
| 2022-12-31 | $206k | 141k | 1.46 |
| 2022-06-30 | $616k | 362k | 1.70 |
| 2022-03-31 | $741k | 360k | 2.06 |
| 2021-12-31 | $1.2M | 309k | 3.75 |
| 2021-09-30 | $1.7M | 330k | 5.17 |
| 2021-03-31 | $250k | 47k | 5.30 |
| 2020-12-31 | $275k | 51k | 5.39 |
| 2020-09-30 | $4.7M | 586k | 7.98 |
| 2020-06-30 | $4.4M | 439k | 10.01 |
| 2019-09-30 | $53k | 35k | 1.50 |
| 2019-06-30 | $116k | 29k | 4.04 |
| 2019-03-31 | $243k | 57k | 4.29 |
| 2018-12-31 | $203k | 35k | 5.74 |
| 2018-09-30 | $357k | 26k | 13.58 |
| 2018-06-30 | $491k | 41k | 11.88 |
| 2018-03-31 | $625k | 56k | 11.23 |
| 2017-12-31 | $584k | 87k | 6.68 |
| 2017-09-30 | $406k | 50k | 8.19 |
| 2017-06-30 | $46k | 10k | 4.49 |
| 2016-06-30 | $160k | 20k | 8.17 |